The medication most people are thinking of is disulfiram, sold under the brand name Antabuse. It is the oldest and most widely recognized drug designed to make you violently ill if you consume alcohol while taking it. Although it is most commonly prescribed as a daily pill, disulfiram has also been studied in injectable and implantable depot forms, which is where the idea of a single “shot” comes from. The reaction it triggers is distinctive and unpleasant enough that the drug’s entire purpose is deterrence: you know what will happen if you drink, so you choose not to.
How Disulfiram Works
Your body processes alcohol in two steps. First, an enzyme converts ethanol into a toxic compound called acetaldehyde. Under normal circumstances, a second enzyme called aldehyde dehydrogenase quickly breaks that acetaldehyde down into harmless acetic acid, essentially vinegar. Disulfiram shuts down that second step. It irreversibly blocks aldehyde dehydrogenase, so acetaldehyde builds up in your bloodstream instead of being cleared.1PubMed. Inhibition of aldehyde dehydrogenase by disulfiram and its metabolite methyl diethylthiocarbamoyl-sulfoxide The buildup is what causes the misery. Acetaldehyde at high concentrations triggers flushing, headache, nausea, and vomiting.2PubMed Central. Disulfiram: Mechanisms, Applications, and Challenges – Section: Use in Addiction
The inhibition is not gentle or partial. Disulfiram and its active metabolite bind to the enzyme and knock it out permanently; your body has to manufacture new enzyme molecules before normal alcohol metabolism resumes.3PubMed. Overview–in vitro inhibition of aldehyde dehydrogenase by disulfiram and metabolites That is why the drug can keep working for days or even a couple of weeks after you stop taking it. It is not sitting in your bloodstream waiting; it has already done its damage to the enzyme, and you are stuck until your body replaces what was lost.
What the Reaction Actually Feels Like
People sometimes underestimate how severe a disulfiram-ethanol reaction can be. The classic experience starts within minutes of drinking and includes intense facial flushing, a pounding headache, nausea, and vomiting. Blood pressure can drop sharply, and in some people consciousness becomes impaired. A hospital study found that flushing, decreased consciousness, and nausea were the hallmark symptoms, and that blood pressure was significantly lower in patients experiencing the reaction compared to other emergency presentations.4PubMed Central. Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward – Section: Results
At the mild end, you feel flushed and nauseated for an hour or two. At the severe end, the reaction can cause dangerous drops in blood pressure, irregular heart rhythms, and respiratory distress. In one documented fatal case, a man with preexisting heart disease resumed drinking after being on disulfiram and went into hypotensive shock, ultimately dying from multi-organ failure.5PubMed Central. Fatal Disulfiram-Ethanol Reaction in a Patient With Preexisting Cardiac Comorbidities: A Case Report That outcome is rare, but it is not theoretical. People with heart conditions, liver disease, or other serious health problems face the greatest danger, which is why prescribing doctors are supposed to screen for those risks before starting the medication.
One underappreciated problem is that emergency room staff do not always recognize the reaction for what it is. That same hospital study found that clinicians failed to consider a disulfiram-ethanol reaction as the diagnosis in roughly 44% of cases where it was the likely cause.4PubMed Central. Recognition of a disulfiram ethanol reaction in the emergency department is not always straightforward – Section: Results The symptoms can mimic allergic reactions, heart attacks, or sepsis, and patients who are intoxicated or semiconscious may not volunteer that they are on disulfiram. If you are taking this medication, carrying a medical ID card or wearing a medical alert bracelet is genuinely important.
The Implant and Injectable Forms
The “shot” framing in the question likely comes from the idea of a depot implant or injection that would keep disulfiram working without the patient needing to take a daily pill. The logic is appealing: if the biggest weakness of an aversion drug is that a motivated drinker can simply stop taking it, then embedding the drug under the skin removes that option. Several depot formulations have been studied over the decades, and some are still used in certain countries.
The reality, though, has been disappointing. Controlled studies of disulfiram implants in both people with alcohol dependence and healthy volunteers have generally failed to demonstrate a reliable pharmacological effect. The main problem is absorption: the drug does not release from the implant site into the bloodstream consistently or in high enough concentrations to produce a strong reaction if the person drinks.6PubMed. Depot preparations of disulfiram: experimental and clinical results A dose-ranging study did find that higher-dose depot formulations combined with an initial oral loading dose could produce sustained alcohol sensitivity for up to four weeks, but the objective reaction only reached statistical significance in the first week or two.7PubMed. Dose-ranging study of depot disulfiram in alcohol abusers
Where disulfiram implants are used clinically, their benefit may be partly psychological. Patients believe the implant is actively protecting them, which reinforces their decision not to drink. That is not nothing — the psychological deterrent may matter more than the pharmacological one in practice — but it does mean the “shot” version of disulfiram is not the foolproof solution some people hope it will be. The oral tablet, taken daily (often under supervision at a clinic), remains the standard form of disulfiram treatment.
Does Disulfiram Actually Help People Stay Sober?
This is where the evidence gets interesting. Disulfiram has been around since the 1950s, and for much of that time it was treated as a somewhat blunt tool — useful in theory but hard to prove effective in rigorous trials, because patients who do not want to take it simply stop. A meta-analysis found that when studies used supervised administration (meaning someone watched the patient take the pill), disulfiram performed significantly better than both naltrexone and acamprosate, the two other FDA-approved medications for alcohol dependence.8PubMed Central. Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis – Section: Results That conditional is critical: disulfiram works well when people actually take it, and supervised dosing makes sure they do.
In unsupervised settings, adherence drops, and so does effectiveness. That is not unique to disulfiram — adherence is a challenge with almost any medication for substance use disorders — but the consequences of non-adherence are more binary here. With naltrexone or acamprosate, missing a dose just means you lose some of the drug’s benefit. With disulfiram, missing doses means the deterrent disappears entirely, and the person can drink without consequence.
Medications That Are Not Disulfiram but Get Confused With It
Disulfiram is the only medication specifically designed to create aversion to alcohol, but several other drugs cause similar reactions as an unintended side effect. The antibiotic metronidazole (Flagyl) is the most commonly encountered culprit. The association between metronidazole and alcohol-induced sickness is well known enough that patients are routinely warned not to drink while taking it, but people do not always realize that alcohol can hide in liquid medications, mouthwashes, and even fermented foods.9PubMed Central. Disulfiram-like Reaction With Metronidazole: An Unsuspected Culprit – Section: Abstract
Certain cephalosporin antibiotics, particularly older ones with a specific chemical side chain, can also trigger disulfiram-like reactions. The same pattern has been reported with some diabetes medications in the sulfonylurea class and with nitrofurantoin, an antibiotic used for urinary tract infections.10PubMed. Disulfiram-like reactions with newer cephalosporins: cefmenoxime If you have ever felt unexpectedly terrible after a single drink while on antibiotics, this is the likeliest explanation. The mechanism varies by drug but generally involves some degree of interference with the same acetaldehyde-clearing enzyme that disulfiram targets.
One early study on the cephalosporin moxalactam demonstrated this directly: some subjects given the antibiotic experienced mild disulfiram-like reactions when they drank, and at least one showed markedly elevated blood acetaldehyde levels, confirming the same buildup mechanism.11PubMed. On the disulfiram-like activity of moxalactam
How Naltrexone and Acamprosate Differ
People searching for “the shot that makes you sick if you drink” sometimes land on naltrexone, particularly its long-acting injectable form (brand name Vivitrol). Naltrexone does come as a once-monthly intramuscular injection, which fits the “shot” description, but it works in a completely different way. It does not make you sick if you drink. Instead, it blocks opioid receptors in the brain, which dampens the pleasurable and reinforcing effects of alcohol. The idea is that drinking becomes less rewarding, so over time you drink less.12PubMed Central. Naltrexone long-acting formulation in the treatment of alcohol dependence – Section: Abstract
Acamprosate (brand name Campral) works through yet another mechanism, helping to restore the balance of brain signaling systems that chronic heavy drinking disrupts. It appears to ease the distress of early sobriety rather than creating aversion or blocking reward.13PubMed Central. Acamprosate for treatment of alcohol dependence: mechanisms, efficacy, and clinical utility – Section: Abstract Acamprosate comes only as an oral tablet taken three times a day.
So if someone tells you they got “a shot for alcoholism,” they could be talking about a disulfiram implant (rare and mostly limited to certain countries), a naltrexone injection (more common, given monthly, does not cause sickness), or possibly an injection of a different medication entirely. Only the disulfiram version creates an aversion reaction. Naltrexone quietly reduces craving and reward. Acamprosate stabilizes brain chemistry during withdrawal and early recovery. Each takes a different approach, and a prescriber’s choice among them depends on the patient’s history, goals, and willingness to comply with dosing.
The Natural Version of This Reaction
Nature stumbled onto the same trick long before pharmaceutical companies did. Certain mushrooms, most notably the common ink cap (Coprinus atramentarius), contain a compound called coprine that blocks aldehyde dehydrogenase in the same way disulfiram does. If you eat these mushrooms and then drink alcohol within a day or two, you get flushing, nausea, and the full suite of symptoms.14PubMed. Poisoning by Coprinus atramentarius The mushrooms themselves are harmless without alcohol; the reaction only occurs when both are in your system.
This effect has been reported with other mushroom species as well. A case series documented similar alcohol intolerance after eating Lepiota aspera, the freckled dapperling, suggesting that coprine-like compounds exist in a wider range of fungi than previously thought.15PubMed. Case series: Alcohol intolerance with Coprine-like syndrome after consumption of the mushroom Lepiota aspera Despite early interest in coprine as a potential alcoholism treatment, researchers found that the compound had troubling toxic properties of its own, including effects on reproductive cells, which ruled it out for medical use.14PubMed. Poisoning by Coprinus atramentarius
The Genetic Version
Some people are born with a built-in version of the disulfiram reaction. A genetic variant common among East Asian populations produces a nonfunctional form of aldehyde dehydrogenase. People who carry two copies of this variant experience intense flushing, nausea, and rapid heartbeat when they drink, because their bodies cannot clear acetaldehyde efficiently. This is widely known as “Asian flush” or “alcohol flush reaction.”16PubMed Central. Genetic Influences Affecting Alcohol Use Among Asians – Section: Abstract
The protective effect is real: people with two copies of the defective gene drink very little and have a much lower risk of developing alcohol use disorder. People with one copy get a milder flush and may push through it, which creates a different kind of risk. Acetaldehyde is not just unpleasant — it is toxic, mutagenic, and has been classified as carcinogenic in animal experiments.17PubMed Central. Acetaldehyde as an underestimated risk factor for cancer development: role of genetics in ethanol metabolism – Section: Abstract People who drink regularly despite the flush are accumulating more acetaldehyde with each session than someone with fully functional enzymes. Research has linked this pattern to elevated risks of esophageal and other upper-digestive-tract cancers.18PubMed Central. Alcohol metabolism and cancer risk – Section: Abstract
This matters for the disulfiram conversation because the drug essentially puts everyone into the same biochemical state that the genetic variant creates naturally. The same logic applies: the reaction is protective against drinking, but the acetaldehyde that causes the reaction is itself harmful. That is part of why disulfiram is meant as a deterrent, not a punishment. The goal is for you to never trigger the reaction at all — to use your knowledge of what would happen as motivation to stay sober.
GLP-1 Medications and the Future of Alcohol Treatment
A newer wave of research has nothing to do with making you sick. GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) were developed for diabetes and weight loss, but patients and researchers started noticing that people on these drugs often lost interest in drinking. A randomized trial found that low-dose semaglutide reduced the amount of alcohol consumed in a laboratory setting, lowered weekly alcohol craving, and predicted greater reductions in heavy drinking over time compared to placebo.19JAMA Psychiatry. Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial – Section: Results
The mechanism appears to involve the brain’s reward circuitry. These drugs seem to dampen the pleasurable response to alcohol, reduce cue-triggered cravings, and blunt the stimulant and sedative effects that drinkers experience.20eClinicalMedicine. Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review and meta-analysis – Section: Results Real-world data from a remote study found that people taking semaglutide or tirzepatide reported significantly lower alcohol intake, fewer binge-drinking episodes, and lower scores on a standard alcohol-problems questionnaire compared to both their own pre-medication baseline and a control group.21Scientific Reports. Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity – Section: Results
These medications are not yet approved for alcohol use disorder, and the research is still in its early chapters. But the concept is philosophically different from disulfiram. Rather than threatening you with misery, GLP-1 drugs seem to quietly dial down the drive to drink in the first place. Whether that approach will prove more effective in the long run, or whether it will work best in combination with other treatments, is something the next several years of clinical trials should help clarify. For now, disulfiram remains the only medication whose entire identity is built around making alcohol a physically punishing experience — and for some people, that blunt-force deterrent is exactly what keeps them alive long enough for other forms of recovery to take hold.